Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Get Free Report) was the target of a large decrease in short interest in September. As of September 30th, there was short interest totaling 557 shares, a decrease of 43.6% from the September 15th total of 988 shares. Based on an average daily trading volume, of 88,151 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.
Healthcare Capital Acquisition Stock Performance
HCAC traded down $0.04 on Thursday, hitting $10.13. The company had a trading volume of 2,611 shares, compared to its average volume of 95,028. The stock has a market capitalization of $377.92 million, a price-to-earnings ratio of 202.60 and a beta of 0.41. The stock has a fifty day moving average price of $10.11 and a 200-day moving average price of $10.05. Healthcare Capital Acquisition has a 12-month low of $9.91 and a 12-month high of $10.18.
Institutional Investors Weigh In On Healthcare Capital Acquisition
An institutional investor recently bought a new position in Healthcare Capital Acquisition stock. Governors Lane LP purchased a new position in shares of Healthcare Capital Acquisition Corp. (NASDAQ:HCAC – Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 275,000 shares of the company’s stock, valued at approximately $2,761,000. Governors Lane LP owned approximately 0.74% of Healthcare Capital Acquisition at the end of the most recent quarter. Institutional investors own 66.82% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Report on Healthcare Capital Acquisition
About Healthcare Capital Acquisition
Healthcare Capital Acquisition Corp. was a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company operating in the healthcare sector.
As a SPAC, the company did not operate healthcare facilities, manufacture medical products, or provide healthcare services of its own. Its primary activities involved raising capital through an initial public offering and evaluating potential merger or acquisition opportunities.
Featured Articles
- Five stocks we like better than Healthcare Capital Acquisition
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Healthcare Capital Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Capital Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
